Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C25H50O4 |
| Molecular Weight | 414.6621 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO
InChI
InChIKey=OKMWKBLSFKFYGZ-UHFFFAOYSA-N
InChI=1S/C25H50O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(28)29-23-24(27)22-26/h24,26-27H,2-23H2,1H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). | 2010-01 |
|
| Solid lipid budesonide microparticles for controlled release inhalation therapy. | 2009-12 |
|
| Solid lipid nanoparticles: a modern formulation approach in drug delivery system. | 2009-07 |
|
| The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). | 2008-06 |
|
| [Studies on the chemical constituents of Lagotis yunnanensis (II)]. | 2006-02 |
|
| Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. | 2006 |
|
| Lipid microparticles as sustained release system for a GnRH antagonist (Antide). | 2003-04-29 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5362585
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
A626UU0W2A
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
30233-64-8
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
C79129
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
142497
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
250-097-0
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
DTXSID60865531
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | |||
|
1655567
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY | RxNorm | ||
|
A626UU0W2A
Created by
admin on Mon Mar 31 17:51:03 GMT 2025 , Edited by admin on Mon Mar 31 17:51:03 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
